These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 27315095
1. Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients. Atkinson W, Catana C, Abramson JS, Arabasz G, McDermott S, Catalano O, Muse V, Blake MA, Barnes J, Shelly M, Hochberg E, Rosen BR, Guimaraes AR. Abdom Radiol (NY); 2016 Jul; 41(7):1338-48. PubMed ID: 27315095 [Abstract] [Full Text] [Related]
2. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME. Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [Abstract] [Full Text] [Related]
6. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF. Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008 [Abstract] [Full Text] [Related]
7. 18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC). Bernstine H, Domachevsky L, Nidam M, Goldberg N, Abadi-Korek I, Shpilberg O, Groshar D. Medicine (Baltimore); 2018 Apr; 97(16):e0490. PubMed ID: 29668631 [Abstract] [Full Text] [Related]
8. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT. Schmidt S, Dunet V, Koehli M, Montemurro M, Meuli R, Prior JO. Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549 [Abstract] [Full Text] [Related]
9. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD. Albano D, Patti C, Matranga D, Lagalla R, Midiri M, Galia M. Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392 [Abstract] [Full Text] [Related]
10. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes. Mosavi F, Wassberg C, Selling J, Molin D, Ahlström H. Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992 [Abstract] [Full Text] [Related]
11. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions. Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ. J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383 [Abstract] [Full Text] [Related]
14. Correlation of mean apparent diffusion coefficient (ADC) and maximal standard uptake value (SUVmax) evaluated by diffusion-weighted MRI and 18F-FDG-PET/CT in children with Hodgkin lymphoma: a feasibility study. Rosbach N, Fischer S, Koch V, Vogl TJ, Bochennek K, Lehrnbecher T, Mahmoudi S, Grünewald L, Grünwald F, Bernatz S. Radiol Oncol; 2023 Jun 01; 57(2):150-157. PubMed ID: 37341195 [Abstract] [Full Text] [Related]
15. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET. Schwenzer NF, Schmidt H, Gatidis S, Brendle C, Müller M, Königsrainer I, Claussen CD, Pfannenberg AC, Schraml C. J Magn Reson Imaging; 2014 Nov 01; 40(5):1121-8. PubMed ID: 24923481 [Abstract] [Full Text] [Related]
16. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer. Xin J, Ma Q, Guo Q, Sun H, Zhang S, Liu C, Zhai W. Eur J Radiol; 2016 Apr 01; 85(4):751-9. PubMed ID: 26971419 [Abstract] [Full Text] [Related]
17. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT. Rauscher I, Eiber M, Fürst S, Souvatzoglou M, Nekolla SG, Ziegler SI, Rummeny EJ, Schwaiger M, Beer AJ. J Nucl Med; 2014 May 01; 55(5):724-9. PubMed ID: 24652827 [Abstract] [Full Text] [Related]
18. 18F-FDG PET/CT in immunocompetent patients with primary central nervous system lymphoma: Differentiation from glioblastoma and correlation with DWI. Zhou W, Wen J, Hua F, Xu W, Lu X, Yin B, Geng D, Guan Y. Eur J Radiol; 2018 Jul 01; 104():26-32. PubMed ID: 29857862 [Abstract] [Full Text] [Related]
19. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results. Heusch P, Buchbender C, Köhler J, Nensa F, Beiderwellen K, Kühl H, Lanzman RS, Wittsack HJ, Gomez B, Gauler T, Schuler M, Forsting M, Bockisch A, Antoch G, Heusner TA. Rofo; 2013 Nov 01; 185(11):1056-62. PubMed ID: 23860802 [Abstract] [Full Text] [Related]
20. Comparison of 3T diffusion-weighted MRI and 18F-FDG PET/CT in musculoskeletal tumours: quantitative analysis of apparent diffusion coefficients and standardized uptake values. Lee SY, Jee WH, Yoo IR, Jung JY, Im SA, Chung YG, Kang JH. Br J Radiol; 2019 Oct 01; 92(1102):20181051. PubMed ID: 31322913 [Abstract] [Full Text] [Related] Page: [Next] [New Search]